These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1510761)

  • 41. Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects.
    Wicher-Muniak E; Zmudka K; Dabroś W; Dudek D; Stachura J
    Pol J Pathol; 1997; 48(1):69-74. PubMed ID: 9200964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F
    Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lupus-like syndrome associated with statin therapy.
    Noël B; Panizzon RG
    Dermatology; 2004; 208(3):276-7. PubMed ID: 15118389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
    Tamburrini LR
    Minerva Med; 1992 Jun; 83(6):347-53. PubMed ID: 1630695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
    Martens LL; Rutten FF; Kuijpens JL; Winter J
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):655-9. PubMed ID: 1903849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lovastatin-induced lupus erythematosus.
    Ahmad S
    Arch Intern Med; 1991 Aug; 151(8):1667-8. PubMed ID: 1872674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-up.
    Behrens-Baumann W; Morawietz A; Thiery J; Creutzfeldt C; Seidel D
    Lens Eye Toxic Res; 1989; 6(1-2):331-7. PubMed ID: 2488025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of HMG-CoA reductase inhibitors on the erythrocyte membrane].
    Rabini RA; Antosiewicz J; Staffolani R; Polenta M; Testa I; Mazzanti L
    Boll Soc Ital Biol Sper; 1991 Feb; 67(2):129-35. PubMed ID: 1653578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia.
    Barth JD; Kruisbrink OA; Van Dijk AL
    BMJ; 1990 Sep; 301(6753):669. PubMed ID: 2224231
    [No Abstract]   [Full Text] [Related]  

  • 52. Ocular drug safety and HMG-CoA-reductase inhibitors.
    Schmidt J; Schmitt C; Hockwin O; Paulus U; von Bergmann K
    Ophthalmic Res; 1994; 26(6):352-60. PubMed ID: 7715916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dropping cholesterol--safely.
    Service RF
    Science; 1994 Nov; 266(5189):1323. PubMed ID: 7973720
    [No Abstract]   [Full Text] [Related]  

  • 54. Drugs recently released in Belgium. Omeprazole--simvastatin.
    Harvengt C
    Acta Clin Belg; 1990; 45(1):60-5. PubMed ID: 2161608
    [No Abstract]   [Full Text] [Related]  

  • 55. HMG-CoA reductase inhibitors for hypercholesterolemia.
    N Engl J Med; 1988 Nov; 319(18):1222-3. PubMed ID: 3173461
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of cerebrotendinous xanthomatosis.
    Federico A; Dotti MT
    Neurology; 1994 Nov; 44(11):2218. PubMed ID: 7970001
    [No Abstract]   [Full Text] [Related]  

  • 57. Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy.
    Manson JM; Freyssinges C; Ducrocq MB; Stephenson WP
    Reprod Toxicol; 1996; 10(6):439-46. PubMed ID: 8946557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HMG-CoA reductase inhibitors. A new approach to the management of hypercholesterolemia.
    Cressman MD; Hoogwerf BJ; Moodie DS; Olin JW; Weinstein CE
    Cleve Clin J Med; 1988; 55(1):93-100. PubMed ID: 3277742
    [No Abstract]   [Full Text] [Related]  

  • 59. Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.
    Chariot P; Abadia R; Agnus D; Danan C; Charpentier C; Gherardi RK
    Am J Med; 1993 Jan; 94(1):109-10. PubMed ID: 8420287
    [No Abstract]   [Full Text] [Related]  

  • 60. Rhabdomyolysis with simvastatin use.
    Berland Y; Vacher Coponat H; Durand C; Baz M; Laugier R; Musso JL
    Nephron; 1991; 57(3):365-6. PubMed ID: 2017280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.